Pay in 4 interest-free payments of $6.05 Learn more
.png)
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Potential treatment for polymorphic light eruption A 2010 phase III, randomized, double blind, placebo controlled, parallel group study was undertaken in Germany, the Netherlands, and Belgium to evaluate the safety and efficacy of subcutaneous implants of melanotan I (16 mg) in patients suffering from polymorphic light eruption (PLE), a condition characterized by a rash following exposure to sunlight
Because the medication slows down gastric emptying, some patients experience constipation
Compare BPC-157 with TB-500 and BPC-157 + TB-500 by vial size, molecule class, category, catalog price, and access status
Customer feedback What is Melanotan? Melanotan 2 (MT2) is a synthetic peptide originally developed by researchers at the University of Arizona as part of efforts to stimulate the body's natural production of melanin
US$ 29.20
US$ 21.68
US$ 28.24
US$ 29.56
US$ 22.18
